TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05931497 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04806633 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04806633 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06530303 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04636437 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study NCT04636437 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06035510 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06466161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05118529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06402968 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04825262 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT05510973 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04779593 — Predictive Biomarker (PRD): HFE mRNA
Genes: HFE; HLAH
Study NCT06600802 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06600802 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06407401 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06611813 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06611813 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06688409 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05562804 — Predictive Biomarker (PRD): MVP mRNA
Genes: MVP; LRP
Study NCT06688071 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06688305 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06495554 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05228015 — Predictive Biomarker (PRD): IK mRNA
Genes: IK; RED; RER
Study NCT04740918 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05975554 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06053411 — Predictive Biomarker (PRD): UGT2B17 mRNA
Genes: UGT2B17
Study NCT05241834 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05029882 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05029882 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05708599 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05664646 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06055699 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05991089 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05993234 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04991454 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06378190 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05144360 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05948943 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT06380712 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04344860 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04344860 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT05879432 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05726630 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05568095 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04934215 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05019521 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05835596 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05483400 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05810311 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06565936 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT06461273 — Predictive Biomarker (PRD): CKM mRNA
Genes: CKM; CKMM
Study NCT06461273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05482035 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05999721 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06011252 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT06565546 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT06253728 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05317871 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05836259 — Predictive Biomarker (PRD): MYBPC3 mRNA
Genes: MYBPC3
Study NCT04984590 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06616766 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06616766 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06683170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06685120 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05419271 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT06694987 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06694272 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06695039 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06689007 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06689462 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT06689462 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06688994 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06690541 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05274451 — Predictive Biomarker (PRD): RORA
Genes: RZRA; ROR1; ROR2; ROR3; NR1F1; ROR-alpha; RORalpha; RORa1
Study NCT04790968 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06636331 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04732221 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05359718 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06584409 — Predictive Biomarker (PRD): MMP2 mRNA
Genes: MMP2; CLG4A
Study NCT05203237 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT04713046 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06393140 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT06494371 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04419389 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05994677 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05738772 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05860296 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT05974111 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06343298 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06642558 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05144997 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05144997 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05349773 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05349773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05933720 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT05495230 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05984992 — Safety Biomarker (SAF): Amphiregulin
Genes: AREG; AREGB; SDGF
Study NCT04615988 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06137482 — Pharmacodynamic Biomarker (PDY): Platelet-derived growth factor B
Genes: PDGFB; PDGF2; SIS
Study NCT06566716 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05149612 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05378425 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05073627 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT06227026 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06213636 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06213636 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05218980 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06679582 — Predictive Biomarker (PRD): CBFA2T3 mRNA
Genes: CBFA2T3; MTG16; MTGR2; ZMYND4
Study NCT06679582 — Predictive Biomarker (PRD): GLIS2 mRNA
Genes: GLIS2; NKL
Study NCT06679582 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT06688643 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06688123 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06690164 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06691061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05792150 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04922073 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05302843 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT05982834 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04942119 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05178693 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT06044623 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06044623 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06044623 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06044623 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05243017 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06042842 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT06222021 — Predictive Biomarker (PRD): SLC16A4 mRNA
Genes: SLC16A4; MCT4; MCT5
Study NCT05635409 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT05756829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05945355 — Predictive Biomarker (PRD); Safety Biomarker (SAF): MHC class I polypeptide-related sequence A
Genes: MICA; PERB11.1
Study NCT06169579 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06169579 — Predictive Biomarker (PRD): NTRK
Study NCT06169579 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT06640400 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06640400 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06640400 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT06236009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06236009 — Pharmacodynamic Biomarker (PDY): Antidrug antibody
Study NCT05396170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06484543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06484543 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05132582 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06628895 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study NCT05938816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05168566 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06219668 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06295159 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05782244 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT06348589 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05078879 — Predictive Biomarker (PRD): G6PC3 mRNA
Genes: G6PC3; UGRP
Study NCT05078879 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06084286 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05252923 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT06125327 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04901715 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05220241 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06006468 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT05712447 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05996068 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05481164 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06500442 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04920825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04920825 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06281106 — Predictive Biomarker (PRD): TYK2 mRNA
Genes: TYK2
Study NCT06281106 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06671054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05006664 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06686199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06633042 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06633042 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06064903 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06686524 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05114291 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05396612 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06309433 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04973891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06517511 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05134519 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05206045 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT05206045 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study NCT05206045 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT05206045 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT06222957 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04949087 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06548295 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06497829 — Predictive Biomarker (PRD): MVK mRNA
Genes: MVK
Study NCT05806372 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05806372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05051657 — Predictive Biomarker (PRD): TYR mRNA
Genes: TYR
Study NCT06411691 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06392750 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06392750 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT04961086 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06419101 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05839847 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05839847 — Predictive Biomarker (PRD): GSR mRNA
Genes: GSR; GLUR; GRD1
Study NCT06152575 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06641505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05883449 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05194787 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06286098 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT04874961 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05999851 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT05999851 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT05999851 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT05999851 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT05999851 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT05979818 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05979818 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05979818 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06097988 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06500689 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06283589 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT05899959 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06054815 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06177327 — Predictive Biomarker (PRD): GNAS mRNA
Genes: GNAS; GNAS1
Study NCT05789849 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05658640 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05848843 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04700072 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04687007 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT04840875 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06687954 — Predictive Biomarker (PRD): PLB1 mRNA
Genes: PLB1; PLB
Study NCT06694532 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06691815 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT06694740 — Predictive Biomarker (PRD): PAICS mRNA
Genes: PAICS; ADE2; AIRC; PAIS
Study NCT06694740 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06695611 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06687941 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study NCT06694350 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04744831 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06454487 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06197802 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06085287 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study NCT05535855 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04684472 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT04684472 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06549907 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06549907 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06549907 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT04884477 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06029166 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05758142 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06536855 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06541080 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study NCT06541080 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04386239 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05422157 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06548620 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06549322 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05149768 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT05792462 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05792462 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT05702047 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04823052 — Predictive Biomarker (PRD): FMR1 mRNA
Genes: FMR1
Study NCT06571084 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT05623605 — Surrogate Endpoint (SUR): Bacterial count
Study NCT06570239 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06304896 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05405270 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study NCT05405270 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04722679 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06229873 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06553898 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06553898 — Predictive Biomarker (PRD): CD70 mRNA
Genes: CD70; CD27L; CD27LG; TNFSF7
Study NCT04677595 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05029999 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT05029999 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05029999 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04966585 — Predictive Biomarker (PRD): CARD9 mRNA
Genes: CARD9
Study NCT05761951 — Predictive Biomarker (PRD): DKK1 mRNA
Genes: DKK1; UNQ492/PRO1008
Study NCT06004674 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06487286 — Safety Biomarker (SAF): Nicotinamide phosphoribosyltransferase
Genes: NAMPT; PBEF; PBEF1
Study NCT06449846 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06164730 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06164730 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06688188 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06690970 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06634160 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06389682 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN